Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.37675797 |
2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.37675797 |
3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.37675797 |
4 | modulation by symbiont of host immune response (GO:0052553) | 6.37675797 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 6.37675797 |
6 | modulation by symbiont of host defense response (GO:0052031) | 6.37675797 |
7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.76948495 |
8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.76948495 |
9 | positive regulation of interferon-alpha production (GO:0032727) | 5.65370405 |
10 | response to type I interferon (GO:0034340) | 5.45584555 |
11 | cellular response to type I interferon (GO:0071357) | 5.45054269 |
12 | type I interferon signaling pathway (GO:0060337) | 5.45054269 |
13 | regulation of interferon-alpha production (GO:0032647) | 5.36011191 |
14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.34045303 |
15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.30187708 |
16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.21981636 |
17 | response to interferon-alpha (GO:0035455) | 4.82126613 |
18 | response to peptidoglycan (GO:0032494) | 4.65098733 |
19 | response to host immune response (GO:0052572) | 4.63361458 |
20 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.63361458 |
21 | macrophage activation involved in immune response (GO:0002281) | 4.53647745 |
22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.50257100 |
23 | response to host (GO:0075136) | 4.20139723 |
24 | response to host defenses (GO:0052200) | 4.20139723 |
25 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.20139723 |
26 | NIK/NF-kappaB signaling (GO:0038061) | 4.19499984 |
27 | positive regulation of interferon-beta production (GO:0032728) | 4.14016298 |
28 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.04075342 |
29 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.02722088 |
30 | response to muramyl dipeptide (GO:0032495) | 4.01067657 |
31 | detection of external biotic stimulus (GO:0098581) | 3.86262509 |
32 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.85943843 |
33 | neutrophil activation involved in immune response (GO:0002283) | 3.82946198 |
34 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.82331734 |
35 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.80812103 |
36 | cellular response to virus (GO:0098586) | 3.80767451 |
37 | regulation of gamma-delta T cell activation (GO:0046643) | 3.78738995 |
38 | I-kappaB phosphorylation (GO:0007252) | 3.78274431 |
39 | negative regulation of viral genome replication (GO:0045071) | 3.78164844 |
40 | positive regulation of antigen processing and presentation (GO:0002579) | 3.77536290 |
41 | regulation of RIG-I signaling pathway (GO:0039535) | 3.77352536 |
42 | detection of bacterium (GO:0016045) | 3.75666673 |
43 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.73854593 |
44 | immunoglobulin mediated immune response (GO:0016064) | 3.72723979 |
45 | negative regulation of T cell mediated immunity (GO:0002710) | 3.66628794 |
46 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.64320842 |
47 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.61991648 |
48 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.59265141 |
49 | natural killer cell mediated immunity (GO:0002228) | 3.59265141 |
50 | microglial cell activation (GO:0001774) | 3.57872392 |
51 | cellular response to interferon-beta (GO:0035458) | 3.55876021 |
52 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.55297411 |
53 | positive regulation of humoral immune response (GO:0002922) | 3.51633419 |
54 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.48906726 |
55 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.47958956 |
56 | cellular response to interferon-alpha (GO:0035457) | 3.44262858 |
57 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.44126452 |
58 | positive regulation of T cell cytokine production (GO:0002726) | 3.40750108 |
59 | positive regulation of interleukin-12 production (GO:0032735) | 3.37891078 |
60 | positive regulation of type 2 immune response (GO:0002830) | 3.36021881 |
61 | detection of biotic stimulus (GO:0009595) | 3.35755601 |
62 | T cell migration (GO:0072678) | 3.34577076 |
63 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.33838090 |
64 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.32086289 |
65 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.27670469 |
66 | B cell receptor signaling pathway (GO:0050853) | 3.26132635 |
67 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.23602680 |
68 | cellular extravasation (GO:0045123) | 3.22606919 |
69 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.22158249 |
70 | defense response to virus (GO:0051607) | 3.19857138 |
71 | regulation of antigen processing and presentation (GO:0002577) | 3.17713555 |
72 | detection of molecule of bacterial origin (GO:0032490) | 3.16604477 |
73 | cellular response to interferon-gamma (GO:0071346) | 3.16334265 |
74 | germinal center formation (GO:0002467) | 3.16156360 |
75 | negative regulation of interleukin-12 production (GO:0032695) | 3.15828038 |
76 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.15529126 |
77 | negative thymic T cell selection (GO:0045060) | 3.15177393 |
78 | regulation of T cell tolerance induction (GO:0002664) | 3.14808916 |
79 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.12473772 |
80 | regulation of interferon-beta production (GO:0032648) | 3.09157355 |
81 | regulation of tolerance induction (GO:0002643) | 3.07384526 |
82 | negative T cell selection (GO:0043383) | 3.07304483 |
83 | response to protozoan (GO:0001562) | 3.06766942 |
84 | myeloid cell activation involved in immune response (GO:0002275) | 3.06618468 |
85 | granulocyte activation (GO:0036230) | 3.06124879 |
86 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.05507471 |
87 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.05326635 |
88 | response to interferon-beta (GO:0035456) | 3.03747670 |
89 | positive regulation of response to biotic stimulus (GO:0002833) | 3.02339024 |
90 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.01203291 |
91 | positive thymic T cell selection (GO:0045059) | 2.99940264 |
92 | T-helper 1 type immune response (GO:0042088) | 2.99754011 |
93 | macrophage activation (GO:0042116) | 2.98896304 |
94 | cellular response to exogenous dsRNA (GO:0071360) | 2.98486990 |
95 | defense response to protozoan (GO:0042832) | 2.95927507 |
96 | response to interleukin-15 (GO:0070672) | 2.95733723 |
97 | neutrophil activation (GO:0042119) | 2.94812642 |
98 | regulation of interleukin-12 production (GO:0032655) | 2.93975977 |
99 | respiratory burst (GO:0045730) | 2.93694619 |
100 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.93129023 |
101 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.90110685 |
102 | positive regulation of interleukin-17 production (GO:0032740) | 2.89804658 |
103 | cellular response to ethanol (GO:0071361) | 2.89046223 |
104 | positive regulation of B cell differentiation (GO:0045579) | 2.88394441 |
105 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.87817509 |
106 | regulation of regulatory T cell differentiation (GO:0045589) | 2.84778177 |
107 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.84412338 |
108 | interferon-gamma production (GO:0032609) | 2.84223214 |
109 | regulation of necroptotic process (GO:0060544) | 2.83068272 |
110 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.81738410 |
111 | leukocyte aggregation (GO:0070486) | 2.81654102 |
112 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.81028095 |
113 | interferon-gamma secretion (GO:0072643) | 2.79952368 |
114 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.78347284 |
115 | detection of other organism (GO:0098543) | 2.78294379 |
116 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.78281939 |
117 | regulation of type 2 immune response (GO:0002828) | 2.77949400 |
118 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.76982014 |
119 | regulation of interleukin-17 production (GO:0032660) | 2.76617890 |
120 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.76521217 |
121 | mature B cell differentiation (GO:0002335) | 2.75755406 |
122 | B cell mediated immunity (GO:0019724) | 2.75213385 |
123 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.74606282 |
124 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.73965486 |
125 | response to interferon-gamma (GO:0034341) | 2.71284548 |
126 | regulation of response to interferon-gamma (GO:0060330) | 2.70477507 |
127 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.70230357 |
128 | regulation of cholesterol storage (GO:0010885) | 2.68336386 |
129 | myeloid dendritic cell differentiation (GO:0043011) | 2.67535236 |
130 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.67057678 |
131 | negative regulation of cell killing (GO:0031342) | 2.67057678 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.98643664 |
2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.12250554 |
3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.89237186 |
4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.65337024 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.50331156 |
6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.05963420 |
7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.64221956 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.57273224 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.51254190 |
10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.37640102 |
11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.00325697 |
12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.90064097 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.82581053 |
14 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.81869255 |
15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.70746314 |
16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.64061145 |
17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.59387296 |
18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.58161893 |
19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.41847854 |
20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.33034382 |
21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.12783043 |
22 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.05485158 |
23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.84376465 |
24 | MAF_26560356_Chip-Seq_TH1_Human | 1.84149742 |
25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83068261 |
26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.79040920 |
27 | MYB_26560356_Chip-Seq_TH2_Human | 1.78361003 |
28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.71227437 |
29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.67924979 |
30 | MYB_26560356_Chip-Seq_TH1_Human | 1.66842962 |
31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.66414586 |
32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60704307 |
33 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.59820013 |
34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.59380454 |
35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51090455 |
36 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.50911250 |
37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.47548819 |
38 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.44627474 |
39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.44455463 |
40 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.43240718 |
41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.42362195 |
42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39437541 |
43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.37156249 |
44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36172893 |
45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.34795745 |
46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34502160 |
47 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32721243 |
48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32263320 |
49 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31043002 |
50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30958428 |
51 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27777708 |
52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.27702062 |
53 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.23833500 |
54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23683720 |
55 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20994190 |
56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20531818 |
57 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19812076 |
58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17742703 |
59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17730697 |
60 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11144814 |
61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06918072 |
62 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05012509 |
63 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03949925 |
64 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00734728 |
65 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99002261 |
66 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98976023 |
67 | MAF_26560356_Chip-Seq_TH2_Human | 0.97725895 |
68 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95757458 |
69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95135143 |
70 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94562876 |
71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94242486 |
72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92593593 |
73 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91190377 |
74 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90815753 |
75 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.88711025 |
76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88476889 |
77 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.87487863 |
78 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86549426 |
79 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86040148 |
80 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86022802 |
81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85681151 |
82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85352488 |
83 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.83516810 |
84 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83042086 |
85 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.81965576 |
86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81804243 |
87 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.78298130 |
88 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.77303466 |
89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77257770 |
90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76967367 |
91 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.76709843 |
92 | MYC_22102868_ChIP-Seq_BL_Human | 0.76576347 |
93 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75917746 |
94 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.75563751 |
95 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.75563751 |
96 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.75452987 |
97 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74436810 |
98 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.74319211 |
99 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74098031 |
100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.74061112 |
101 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73109521 |
102 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.72914885 |
103 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.69716658 |
104 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.68117836 |
105 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.68113279 |
106 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.67621032 |
107 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67603996 |
108 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67236376 |
109 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66233006 |
110 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.65609361 |
111 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65000196 |
112 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63207440 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.23813703 |
2 | MP0009785_altered_susceptibility_to | 3.82278657 |
3 | MP0003303_peritoneal_inflammation | 3.33720731 |
4 | MP0003436_decreased_susceptibility_to | 3.27557033 |
5 | MP0000685_abnormal_immune_system | 3.26817400 |
6 | MP0001790_abnormal_immune_system | 3.18512141 |
7 | MP0005387_immune_system_phenotype | 3.18512141 |
8 | MP0005025_abnormal_response_to | 2.92686096 |
9 | MP0005000_abnormal_immune_tolerance | 2.86278345 |
10 | MP0003724_increased_susceptibility_to | 2.86187229 |
11 | MP0002419_abnormal_innate_immunity | 2.77837020 |
12 | MP0004510_myositis | 2.77726271 |
13 | MP0006082_CNS_inflammation | 2.75646598 |
14 | MP0002148_abnormal_hypersensitivity_rea | 2.72643490 |
15 | MP0001800_abnormal_humoral_immune | 2.71536586 |
16 | MP0002452_abnormal_antigen_presenting | 2.58925076 |
17 | MP0002723_abnormal_immune_serum | 2.50380496 |
18 | MP0005671_abnormal_response_to | 2.45426514 |
19 | MP0005058_abnormal_lysosome_morphology | 2.45334434 |
20 | MP0004947_skin_inflammation | 2.27365072 |
21 | MP0001819_abnormal_immune_cell | 2.17522194 |
22 | MP0000569_abnormal_digit_pigmentation | 2.14300858 |
23 | MP0002420_abnormal_adaptive_immunity | 2.12769251 |
24 | MP0005464_abnormal_platelet_physiology | 1.92010359 |
25 | MP0005451_abnormal_body_composition | 1.90444778 |
26 | MP0010155_abnormal_intestine_physiology | 1.87896692 |
27 | MP0009840_abnormal_foam_cell | 1.86466638 |
28 | MP0001533_abnormal_skeleton_physiology | 1.85990607 |
29 | MP0003172_abnormal_lysosome_physiology | 1.85636670 |
30 | MP0009764_decreased_sensitivity_to | 1.83953360 |
31 | MP0002166_altered_tumor_susceptibility | 1.83836161 |
32 | MP0003300_gastrointestinal_ulcer | 1.81416379 |
33 | MP0001845_abnormal_inflammatory_respons | 1.81164001 |
34 | MP0008469_abnormal_protein_level | 1.77010469 |
35 | MP0001853_heart_inflammation | 1.76754173 |
36 | MP0002006_tumorigenesis | 1.76683434 |
37 | MP0009278_abnormal_bone_marrow | 1.75812563 |
38 | MP0002405_respiratory_system_inflammati | 1.73136805 |
39 | MP0000716_abnormal_immune_system | 1.64172151 |
40 | MP0002398_abnormal_bone_marrow | 1.61350219 |
41 | MP0003448_altered_tumor_morphology | 1.60039270 |
42 | MP0003191_abnormal_cellular_cholesterol | 1.58390865 |
43 | MP0000604_amyloidosis | 1.50004686 |
44 | MP0004883_abnormal_blood_vessel | 1.42654828 |
45 | MP0001545_abnormal_hematopoietic_system | 1.42400532 |
46 | MP0005397_hematopoietic_system_phenotyp | 1.42400532 |
47 | MP0005310_abnormal_salivary_gland | 1.37794208 |
48 | MP0000689_abnormal_spleen_morphology | 1.34611246 |
49 | MP0002998_abnormal_bone_remodeling | 1.32856412 |
50 | MP0002429_abnormal_blood_cell | 1.30642435 |
51 | MP0008260_abnormal_autophagy | 1.28483774 |
52 | MP0002254_reproductive_system_inflammat | 1.27817709 |
53 | MP0000343_altered_response_to | 1.26987544 |
54 | MP0003075_altered_response_to | 1.24273619 |
55 | MP0003763_abnormal_thymus_physiology | 1.24027078 |
56 | MP0010307_abnormal_tumor_latency | 1.23934731 |
57 | MP0009763_increased_sensitivity_to | 1.22405459 |
58 | MP0002722_abnormal_immune_system | 1.21587649 |
59 | MP0009333_abnormal_splenocyte_physiolog | 1.21464862 |
60 | MP0002138_abnormal_hepatobiliary_system | 1.21324956 |
61 | MP0000465_gastrointestinal_hemorrhage | 1.18904683 |
62 | MP0005083_abnormal_biliary_tract | 1.14718478 |
63 | MP0002332_abnormal_exercise_endurance | 1.13555958 |
64 | MP0001873_stomach_inflammation | 1.13039043 |
65 | MP0003183_abnormal_peptide_metabolism | 1.12337412 |
66 | MP0005360_urolithiasis | 1.07670864 |
67 | MP0000858_altered_metastatic_potential | 1.07179735 |
68 | MP0005167_abnormal_blood-brain_barrier | 1.06889699 |
69 | MP0006054_spinal_hemorrhage | 1.06097251 |
70 | MP0005166_decreased_susceptibility_to | 1.05053456 |
71 | MP0004808_abnormal_hematopoietic_stem | 1.03795122 |
72 | MP0004381_abnormal_hair_follicle | 1.03322982 |
73 | MP0003091_abnormal_cell_migration | 1.03193283 |
74 | MP0008004_abnormal_stomach_pH | 1.01001672 |
75 | MP0005076_abnormal_cell_differentiation | 0.95022781 |
76 | MP0005174_abnormal_tail_pigmentation | 0.94456924 |
77 | MP0003453_abnormal_keratinocyte_physiol | 0.93165892 |
78 | MP0003690_abnormal_glial_cell | 0.90289583 |
79 | MP0004782_abnormal_surfactant_physiolog | 0.88127649 |
80 | MP0000609_abnormal_liver_physiology | 0.87853672 |
81 | MP0003566_abnormal_cell_adhesion | 0.87489384 |
82 | MP0000371_diluted_coat_color | 0.85683476 |
83 | MP0003045_fibrosis | 0.84071091 |
84 | MP0005164_abnormal_response_to | 0.83844835 |
85 | MP0010352_gastrointestinal_tract_polyps | 0.82513019 |
86 | MP0001851_eye_inflammation | 0.82006882 |
87 | MP0002933_joint_inflammation | 0.81094554 |
88 | MP0000249_abnormal_blood_vessel | 0.80454038 |
89 | MP0003705_abnormal_hypodermis_morpholog | 0.78356272 |
90 | MP0005390_skeleton_phenotype | 0.77319135 |
91 | MP0003828_pulmonary_edema | 0.77004257 |
92 | MP0002139_abnormal_hepatobiliary_system | 0.76792026 |
93 | MP0002277_abnormal_respiratory_mucosa | 0.76386208 |
94 | MP0001663_abnormal_digestive_system | 0.76162922 |
95 | MP0009765_abnormal_xenobiotic_induced | 0.75390041 |
96 | MP0000703_abnormal_thymus_morphology | 0.74019433 |
97 | MP0002136_abnormal_kidney_physiology | 0.73636893 |
98 | MP0003866_abnormal_defecation | 0.72991263 |
99 | MP0003221_abnormal_cardiomyocyte_apopto | 0.72383363 |
100 | MP0008057_abnormal_DNA_replication | 0.71560027 |
101 | MP0005023_abnormal_wound_healing | 0.70069865 |
102 | MP0002396_abnormal_hematopoietic_system | 0.69896961 |
103 | MP0000767_abnormal_smooth_muscle | 0.69447713 |
104 | MP0003656_abnormal_erythrocyte_physiolo | 0.69393664 |
105 | MP0001958_emphysema | 0.67077585 |
106 | MP0001881_abnormal_mammary_gland | 0.67034477 |
107 | MP0004858_abnormal_nervous_system | 0.66709094 |
108 | MP0005319_abnormal_enzyme/_coenzyme | 0.63945743 |
109 | MP0003195_calcinosis | 0.62719422 |
110 | MP0005075_abnormal_melanosome_morpholog | 0.61963847 |
111 | MP0003806_abnormal_nucleotide_metabolis | 0.61674385 |
112 | MP0008874_decreased_physiological_sensi | 0.60166648 |
113 | MP0003795_abnormal_bone_structure | 0.59853445 |
114 | MP0002132_abnormal_respiratory_system | 0.59545695 |
115 | MP0002877_abnormal_melanocyte_morpholog | 0.59148576 |
116 | MP0000015_abnormal_ear_pigmentation | 0.58635015 |
117 | MP0000598_abnormal_liver_morphology | 0.57825014 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.63984646 |
2 | Eczematoid dermatitis (HP:0000976) | 5.55484610 |
3 | Recurrent bacterial skin infections (HP:0005406) | 5.37574502 |
4 | Autoimmune thrombocytopenia (HP:0001973) | 4.79592495 |
5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.61199986 |
6 | Myositis (HP:0100614) | 4.55683151 |
7 | Orchitis (HP:0100796) | 4.52718933 |
8 | Mediastinal lymphadenopathy (HP:0100721) | 4.44638941 |
9 | Optic neuritis (HP:0100653) | 4.43915517 |
10 | Retrobulbar optic neuritis (HP:0100654) | 4.43915517 |
11 | Abnormality of macrophages (HP:0004311) | 4.41114094 |
12 | Chronic otitis media (HP:0000389) | 4.39982471 |
13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.24462846 |
14 | Recurrent viral infections (HP:0004429) | 4.11108133 |
15 | Recurrent fungal infections (HP:0002841) | 3.89761254 |
16 | Vasculitis (HP:0002633) | 3.78048718 |
17 | Recurrent skin infections (HP:0001581) | 3.72479728 |
18 | Systemic lupus erythematosus (HP:0002725) | 3.50590359 |
19 | Vacuolated lymphocytes (HP:0001922) | 3.45381142 |
20 | Gingivitis (HP:0000230) | 3.38260466 |
21 | Nasal polyposis (HP:0100582) | 3.30927759 |
22 | Basal ganglia calcification (HP:0002135) | 3.27170950 |
23 | Stomatitis (HP:0010280) | 3.26375547 |
24 | Increased cerebral lipofuscin (HP:0011813) | 3.25728696 |
25 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.23175132 |
26 | Pulmonary infiltrates (HP:0002113) | 3.18922436 |
27 | Arterial thrombosis (HP:0004420) | 3.17032202 |
28 | Periodontitis (HP:0000704) | 3.16752918 |
29 | Increased IgM level (HP:0003496) | 3.13282847 |
30 | Abnormality of the nasal mucosa (HP:0000433) | 3.10081285 |
31 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.09387286 |
32 | Recurrent cutaneous fungal infections (HP:0011370) | 3.09387286 |
33 | Myocardial infarction (HP:0001658) | 3.01151131 |
34 | Recurrent bronchitis (HP:0002837) | 2.97123353 |
35 | Gingival bleeding (HP:0000225) | 2.96823497 |
36 | Pustule (HP:0200039) | 2.96755713 |
37 | Hematochezia (HP:0002573) | 2.95265733 |
38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.94756591 |
39 | Porencephaly (HP:0002132) | 2.89947860 |
40 | Thick nail (HP:0001805) | 2.83540972 |
41 | Hypergammaglobulinemia (HP:0010702) | 2.80969410 |
42 | Keratoconjunctivitis sicca (HP:0001097) | 2.78162603 |
43 | Prostate neoplasm (HP:0100787) | 2.73443987 |
44 | Premature loss of primary teeth (HP:0006323) | 2.72184239 |
45 | Tetraparesis (HP:0002273) | 2.65065941 |
46 | Hemoptysis (HP:0002105) | 2.63526287 |
47 | Cellulitis (HP:0100658) | 2.63326642 |
48 | Interstitial pulmonary disease (HP:0006530) | 2.63313335 |
49 | Colitis (HP:0002583) | 2.60449141 |
50 | Osteomyelitis (HP:0002754) | 2.57839359 |
51 | Gastrointestinal infarctions (HP:0005244) | 2.55464771 |
52 | Obstructive lung disease (HP:0006536) | 2.53485179 |
53 | Chronic obstructive pulmonary disease (HP:0006510) | 2.53485179 |
54 | Keratoconjunctivitis (HP:0001096) | 2.52670693 |
55 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.50978069 |
56 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.50978069 |
57 | Abnormality of glycolipid metabolism (HP:0010969) | 2.50978069 |
58 | Meningitis (HP:0001287) | 2.50270620 |
59 | Glomerulonephritis (HP:0000099) | 2.49173704 |
60 | Increased IgE level (HP:0003212) | 2.49089740 |
61 | Panhypogammaglobulinemia (HP:0003139) | 2.45315425 |
62 | Leukocytosis (HP:0001974) | 2.44237783 |
63 | Abnormality of T cell number (HP:0011839) | 2.43529906 |
64 | Chronic sinusitis (HP:0011109) | 2.37841903 |
65 | Joint swelling (HP:0001386) | 2.37737897 |
66 | Abnormality of the pleura (HP:0002103) | 2.37462739 |
67 | Osteolytic defects of the hand bones (HP:0009699) | 2.37039804 |
68 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.37039804 |
69 | Axonal loss (HP:0003447) | 2.34943431 |
70 | Esophageal varix (HP:0002040) | 2.31287388 |
71 | Loss of speech (HP:0002371) | 2.30810140 |
72 | Viral hepatitis (HP:0006562) | 2.30212353 |
73 | Nephritis (HP:0000123) | 2.30013744 |
74 | Eosinophilia (HP:0001880) | 2.25716440 |
75 | Abnormality of T cell physiology (HP:0011840) | 2.25712318 |
76 | Inflammation of the large intestine (HP:0002037) | 2.25368230 |
77 | Spontaneous hematomas (HP:0007420) | 2.25196511 |
78 | T lymphocytopenia (HP:0005403) | 2.23090267 |
79 | Abnormality of the peritoneum (HP:0002585) | 2.20684531 |
80 | Emphysema (HP:0002097) | 2.19891677 |
81 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.19756669 |
82 | Urticaria (HP:0001025) | 2.19613271 |
83 | Anorexia (HP:0002039) | 2.18647065 |
84 | Abnormality of the endocardium (HP:0004306) | 2.18420656 |
85 | Autoimmune hemolytic anemia (HP:0001890) | 2.17351302 |
86 | Abnormality of B cell number (HP:0010975) | 2.17135934 |
87 | Frequent falls (HP:0002359) | 2.15374984 |
88 | Gastrointestinal inflammation (HP:0004386) | 2.14677030 |
89 | Prolonged bleeding time (HP:0003010) | 2.13892797 |
90 | Plagiocephaly (HP:0001357) | 2.13038330 |
91 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.12797668 |
92 | Lymphopenia (HP:0001888) | 2.12657862 |
93 | Joint hemorrhage (HP:0005261) | 2.12539195 |
94 | Bone pain (HP:0002653) | 2.10160769 |
95 | Amyloidosis (HP:0011034) | 2.07190419 |
96 | Slow saccadic eye movements (HP:0000514) | 2.04701224 |
97 | Abnormality of eosinophils (HP:0001879) | 2.03983861 |
98 | Recurrent pneumonia (HP:0006532) | 2.01481361 |
99 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.00500686 |
100 | Skin ulcer (HP:0200042) | 1.99967953 |
101 | Cheilitis (HP:0100825) | 1.99828869 |
102 | Malnutrition (HP:0004395) | 1.99737949 |
103 | IgG deficiency (HP:0004315) | 1.99443824 |
104 | IgM deficiency (HP:0002850) | 1.99141742 |
105 | Agammaglobulinemia (HP:0004432) | 1.99056092 |
106 | Epistaxis (HP:0000421) | 1.99016771 |
107 | IgA deficiency (HP:0002720) | 1.98598861 |
108 | Glomerulopathy (HP:0100820) | 1.98573745 |
109 | Pulmonary embolism (HP:0002204) | 1.98330767 |
110 | Chest pain (HP:0100749) | 1.96212481 |
111 | Gastrointestinal stroma tumor (HP:0100723) | 1.96098874 |
112 | Abnormality of T cells (HP:0002843) | 1.95972641 |
113 | Thrombophlebitis (HP:0004418) | 1.95787374 |
114 | Polyneuropathy (HP:0001271) | 1.94710881 |
115 | Arthralgia (HP:0002829) | 1.94380245 |
116 | Acute hepatic failure (HP:0006554) | 1.94262556 |
117 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.93830527 |
118 | Subacute progressive viral hepatitis (HP:0006572) | 1.93719299 |
119 | Abnormality of the pericardium (HP:0001697) | 1.92702662 |
120 | Vertigo (HP:0002321) | 1.92601832 |
121 | Disinhibition (HP:0000734) | 1.91579851 |
122 | Chronic diarrhea (HP:0002028) | 1.91277528 |
123 | Encephalitis (HP:0002383) | 1.91028461 |
124 | Keratitis (HP:0000491) | 1.89462187 |
125 | Peritonitis (HP:0002586) | 1.88569391 |
126 | Granulocytopenia (HP:0001913) | 1.87099325 |
127 | Complement deficiency (HP:0004431) | 1.85538837 |
128 | Gangrene (HP:0100758) | 1.85382530 |
129 | Recurrent lower respiratory tract infections (HP:0002783) | 1.85111090 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TYK2 | 4.73031176 |
2 | MAP3K14 | 4.15853279 |
3 | IKBKE | 3.98334248 |
4 | TBK1 | 3.61449473 |
5 | JAK3 | 3.32486453 |
6 | JAK1 | 3.22565838 |
7 | IRAK3 | 3.04496385 |
8 | RIPK4 | 3.03225313 |
9 | MAP4K1 | 2.80124235 |
10 | IRAK4 | 2.71184868 |
11 | MAP3K13 | 2.66443537 |
12 | BLK | 2.66405866 |
13 | FGFR4 | 2.54009145 |
14 | KIT | 2.49816900 |
15 | ERN1 | 2.21902079 |
16 | IKBKB | 2.21010252 |
17 | TXK | 2.05895630 |
18 | PRPF4B | 1.87190430 |
19 | FGFR3 | 1.69768797 |
20 | EPHB1 | 1.58784369 |
21 | CSK | 1.55960787 |
22 | CHUK | 1.53913096 |
23 | TAOK3 | 1.43186061 |
24 | ZAP70 | 1.42643145 |
25 | MAP3K10 | 1.36909174 |
26 | SYK | 1.28638277 |
27 | PBK | 1.28117093 |
28 | HCK | 1.27611340 |
29 | JAK2 | 1.25638146 |
30 | GRK7 | 1.19764610 |
31 | LCK | 1.18570528 |
32 | CDC42BPA | 1.16402219 |
33 | EPHA3 | 1.15315809 |
34 | PIK3CG | 1.13457131 |
35 | CSF1R | 1.05358789 |
36 | PIM2 | 1.02229598 |
37 | MARK3 | 1.01265886 |
38 | RPS6KA4 | 0.99870274 |
39 | FGR | 0.98485396 |
40 | TTN | 0.98424331 |
41 | BTK | 0.96459622 |
42 | PTK6 | 0.96220479 |
43 | STK10 | 0.96213901 |
44 | CDK12 | 0.95735910 |
45 | TGFBR2 | 0.95685390 |
46 | IRAK1 | 0.93658053 |
47 | RIPK1 | 0.93356075 |
48 | SIK2 | 0.92711072 |
49 | FES | 0.89347653 |
50 | CAMK1D | 0.89218858 |
51 | PIM1 | 0.89154466 |
52 | TNK2 | 0.85661085 |
53 | LYN | 0.85439504 |
54 | MAP3K2 | 0.82327216 |
55 | EIF2AK2 | 0.79331721 |
56 | NEK9 | 0.78290077 |
57 | SIK1 | 0.75305436 |
58 | ACVR1B | 0.73861810 |
59 | TEC | 0.73237432 |
60 | STK4 | 0.71986754 |
61 | TAOK1 | 0.71443720 |
62 | MST4 | 0.70933831 |
63 | MAP3K5 | 0.69660208 |
64 | ITK | 0.69316994 |
65 | EGFR | 0.69276115 |
66 | HIPK2 | 0.68096326 |
67 | MATK | 0.67243771 |
68 | PTK2B | 0.66518859 |
69 | MST1R | 0.62760662 |
70 | DAPK2 | 0.62759820 |
71 | STK3 | 0.61843941 |
72 | MAP3K11 | 0.61154215 |
73 | TAOK2 | 0.60679098 |
74 | MARK2 | 0.60276028 |
75 | BMX | 0.59951218 |
76 | CAMKK2 | 0.56724841 |
77 | MAPK7 | 0.56525490 |
78 | MAP3K6 | 0.55278110 |
79 | SGK2 | 0.54059727 |
80 | TRPM7 | 0.53917055 |
81 | IRAK2 | 0.53672653 |
82 | ABL1 | 0.53436070 |
83 | FRK | 0.52589813 |
84 | MELK | 0.52471425 |
85 | PRKCQ | 0.51738800 |
86 | LRRK2 | 0.51225322 |
87 | CAMK1G | 0.50997212 |
88 | TRIB3 | 0.50028496 |
89 | NLK | 0.47714007 |
90 | BMPR2 | 0.45956569 |
91 | CDK6 | 0.45918007 |
92 | WNK1 | 0.45326194 |
93 | PKN2 | 0.44687731 |
94 | SIK3 | 0.44630795 |
95 | GRK6 | 0.44500158 |
96 | NME2 | 0.44157560 |
97 | MAPK11 | 0.42768798 |
98 | KSR2 | 0.42264590 |
99 | KDR | 0.41671226 |
100 | MAP2K3 | 0.40011324 |
101 | DDR2 | 0.38600515 |
102 | YES1 | 0.38020885 |
103 | PRKCD | 0.37762215 |
104 | MAP3K7 | 0.37325154 |
105 | MAP2K6 | 0.35987308 |
106 | PDGFRB | 0.35358695 |
107 | DAPK3 | 0.33734999 |
108 | PDK1 | 0.32735745 |
109 | NUAK1 | 0.31235730 |
110 | CLK1 | 0.30964464 |
111 | PDPK1 | 0.30849573 |
112 | PKN1 | 0.30712029 |
113 | FYN | 0.29887246 |
114 | RET | 0.29850555 |
115 | SGK3 | 0.29816120 |
116 | MAP3K3 | 0.29635918 |
117 | MOS | 0.27667655 |
118 | RPS6KA5 | 0.26756625 |
119 | STK24 | 0.25622229 |
120 | FLT3 | 0.23362669 |
121 | IGF1R | 0.22495414 |
122 | PRKAA2 | 0.22489727 |
123 | CDK4 | 0.21673109 |
124 | PRKG2 | 0.21611439 |
125 | INSR | 0.21421433 |
126 | ABL2 | 0.21221307 |
127 | MAPKAPK2 | 0.20023859 |
128 | MAP3K1 | 0.19966876 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.02533993 |
2 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.91669745 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.89250171 |
4 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.89125371 |
5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.85279448 |
6 | Measles_Homo sapiens_hsa05162 | 2.77278964 |
7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.62902970 |
8 | Allograft rejection_Homo sapiens_hsa05330 | 2.45648136 |
9 | Influenza A_Homo sapiens_hsa05164 | 2.45207844 |
10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.40137694 |
11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.38180446 |
12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.32301570 |
13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.11077238 |
14 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.07208875 |
15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.05088198 |
16 | Malaria_Homo sapiens_hsa05144 | 2.00695931 |
17 | Pertussis_Homo sapiens_hsa05133 | 2.00330198 |
18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.98350123 |
19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.96034769 |
20 | Legionellosis_Homo sapiens_hsa05134 | 1.94993972 |
21 | Tuberculosis_Homo sapiens_hsa05152 | 1.93053545 |
22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.86252941 |
23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.76893057 |
24 | Hepatitis C_Homo sapiens_hsa05160 | 1.69313250 |
25 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.67861550 |
26 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.54583587 |
27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49840065 |
28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.49790529 |
29 | Asthma_Homo sapiens_hsa05310 | 1.46521950 |
30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.43484668 |
31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40412213 |
32 | Apoptosis_Homo sapiens_hsa04210 | 1.38625239 |
33 | Hepatitis B_Homo sapiens_hsa05161 | 1.37261441 |
34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32959775 |
35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.28577813 |
36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.26936338 |
37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24815117 |
38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24699044 |
39 | Lysosome_Homo sapiens_hsa04142 | 1.17769232 |
40 | Salmonella infection_Homo sapiens_hsa05132 | 1.17267497 |
41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.15531868 |
42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12125674 |
43 | Shigellosis_Homo sapiens_hsa05131 | 1.11674423 |
44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11474501 |
45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.11045141 |
46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10425670 |
47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01026474 |
48 | Phagosome_Homo sapiens_hsa04145 | 0.99710300 |
49 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98023215 |
50 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.97909943 |
51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.91749128 |
52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89890540 |
53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.84991134 |
54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83691907 |
55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83619952 |
56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.82294962 |
57 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.82162116 |
58 | Amoebiasis_Homo sapiens_hsa05146 | 0.79604507 |
59 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78988157 |
60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78536479 |
61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73872698 |
62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70988026 |
63 | ABC transporters_Homo sapiens_hsa02010 | 0.69994185 |
64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64538881 |
65 | Insulin resistance_Homo sapiens_hsa04931 | 0.63535169 |
66 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61369802 |
67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54459334 |
68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54273458 |
69 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.53874671 |
70 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.51786520 |
71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51370943 |
72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51369961 |
73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50928171 |
74 | Platelet activation_Homo sapiens_hsa04611 | 0.48258215 |
75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46685930 |
76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46296808 |
77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44006344 |
78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43858267 |
79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42131297 |
80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40493841 |
81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39321659 |
82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38936575 |
83 | Prion diseases_Homo sapiens_hsa05020 | 0.38662252 |
84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38312837 |
85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36998815 |
86 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.36797173 |
87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36514908 |
88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.36093560 |
89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35973770 |
90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35419030 |
91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32842064 |
92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30737544 |
93 | Lysine degradation_Homo sapiens_hsa00310 | 0.30230524 |
94 | Endocytosis_Homo sapiens_hsa04144 | 0.30172696 |
95 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29747745 |
96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29022594 |
97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.28531552 |
98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.26710033 |
99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26588037 |
100 | Mineral absorption_Homo sapiens_hsa04978 | 0.26202487 |
101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.25900281 |
102 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.25564202 |
103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25407219 |
104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.24597311 |
105 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23834062 |
106 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.23787880 |
107 | Bladder cancer_Homo sapiens_hsa05219 | 0.22753161 |
108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.22318289 |
109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21405335 |
110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.21031664 |
111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20305076 |
112 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.19989443 |
113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.19609520 |
114 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.19265625 |
115 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.15657853 |
116 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.14796810 |
117 | Prostate cancer_Homo sapiens_hsa05215 | 0.13809915 |
118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.12983049 |